Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 January 2022 : Clinical Research  

A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines

Tomasz Korzeniowski12ABCDEFG*, Jerzy Strużyna13ACDEFG, Anna M. Chrapusta4ABCDE, Andrzej Krajewski5ABDE, Marek Kucharzewski6ABDEF, Krzysztof Piorun ORCID logo5ABCE, Jakub Nowakowski7BCDF, Agnieszka Surowiecka1ACDE, Magdalena Kozicka12ABDF, Kamil Torres12BDEG

DOI: 10.12659/MSM.935632

Med Sci Monit 2022; 28:e935632

Table 4 Consensus statements and agreement on post-enzymatic debridement wound care.

NoStatementAgreementLikert scaleConsensus
15Local evaluation by an experienced member of the burn team is crucial in terms of adopting the right approach to post-enzymatic debridement wound management100%4/5 strongly agree1/5 agreeYes
16The color of the wound bed and post-enzymatic debridement bleeding patterns play an important role in burn wound depth diagnosis100%5/5 strongly agreeYes
17The key aspect of post-enzymatic debridement wound management involves preventing the wound from drying and keeping the wound moist100%5/5 strongly agreeYes
18Full-thickness wounds require early skin grafting100%4/5 strongly agree1/5 somewhat agreeYes
19Special dressings (eg, silicone, hydrocolloid, or membrane dressings) or allografts are recommended for use if epithelialization is expected or as a means of preparing the wound for grafting100%3/5 strongly agree1/5 agree1/5 somewhat agreeYes
20If pseudoeschar lasts >14 days, repeated wound debridement needs to be considered100%4/5 strongly agree1/5 agreeYes
21If epithelialization fails to progress for 21 days in partial-thickness wounds, autologous skin grafts need to be considered100%5/5 strongly agreeYes

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750